Gautheron J, Morisseau C, Chung WK, Zammouri J, Auclair M, Baujat G, Capel E, Moulin C, Wang Y, Yang J, Hammock BD, Cerame B, Phan F, Feve B, Vigouroux C, Andreelli F, Jeru I (2021) <br />EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence<br /><i>Elife</i> <b>10</b>: <br /><br />Sollier C, Capel E, Aguilhon C, Smirnov V, Auclair M, Douillard C, Ladsous M, Defoort-Dhellemmes S, Gorwood J, Braud L, Motterlini R, Vatier C, Lascols O, Renard E, Vigouroux C, Jeru I (2021) <br />LIPE-related lipodystrophic syndrome: clinical characteristics and disease modelling using adipose stem cells<br /><i>European Journal of Endocrinology</i> <b>184</b>: 155<br /><br />Sollier C, Vatier C, Capel E, Lascols O, Auclair M, Janmaat S, Feve B, Jeru I, Vigouroux C (2020) <br />Lipodystrophic syndromes: From diagnosis to treatment<br /><i>Ann Endocrinol (Paris)</i> <b>81</b>: 51<br /><br />